top of page

Houston Oncology Summit: Oppenheimer analysts Jeff Jones and Jay Olson talk radiopharmaceuticals and antibody-drug conjugates

Jeff Jones notes how radioisotopes are being added to more than just antibodies, and calls out upcoming data from Perspective Therapeutics. Then, Jay Olson highlights ADC targets to watch while highlighting Bicycle and Sutro.



Brought to you by:


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

SAV_Logo_2024.png

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

bottom of page